bpc-157 dosage clinical trials BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage Protocol: Injection Guide
Description
Reynolds et al
We normally include information about a peptides timeline of benefits, but to do the same with KPV would require an unreasonable amount of unhelpful conjecture
For research content, the safer focus is compound identity, study models, purity, COA testing, and laboratory handling
A penile injection helps you have an erection
